Why the study?
Does the Hardman index predict mortality in patients undergoing open or endovascular repair of ruptured abdominal aortic aneurysm?
Does the Hardman index predict mortality in patients undergoing open or endovascular repair of ruptured abdominal aortic aneurysm?
The Hardman index correlates well with mortality in both open and endovascular rAAA repair, and patients with a score <2 may have a survival benefit with endovascular repair.
Answers are grounded in this paper and cite their sources.
Loss of consciousness aids risk stratification in rAAA repair; leaves open endovascular survival benefit in observational data.
PURPOSE: To correlate the Hardman prognostic index with perioperative mortality in patients undergoing open and endovascular repair of ruptured abdominal aortic aneurysm (rAAA). METHODS: Over a 5-year period, 126 patients (109 men; mean age 74 years, range 51-91) underwent open (n=74) or endovascular (n=52) repair of rAAA in a single unit. Five Hardman factors (age>76 years, history of loss of consciousness, ECG evidence of ischemia, hemoglobin<9.0 g/dL, and serum creatinine>0.19 mmol/L) were assessed, and their association with in-hospital or 30-day mortality was evaluated retrospectively by chi-square or logistic regression analysis. RESULTS: The mortality for open repair was 51.4% (38/74) in comparison to 32.7% (17/52) for the endovascular group (p=0.05). On multivariate analysis, loss of consciousness (p=0.03, OR 2.9, 95% CI 1.1 to 7.5) was the only significant predictor of mortality in both groups. The mortality rates for open repair patients with Hardman scores<2 were 43.5% (20/46) in comparison to 22.9% (8/35) for the endovascular group (p=0.06), whereas mortality rates for patients with scores>or=2 were 64.3% (18/28) and 52.9% (9/17) for the respective groups (p=0.54). CONCLUSION: The Hardman index correlates well with mortality in both the open and endovascular groups. Those with a score<2 have a trend toward better survival following endovascular repair compared to open repair, while this benefit is not obvious in patients with a score>or=2.
No takes yet. Share an insight, caveat, or question.
Sharif et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: